224 related articles for article (PubMed ID: 30132539)
1. Hydroxysafflor yellow A protects against angiotensin II‑induced hypertrophy.
Ni B; Zhou D; Jing Y; Liu S
Mol Med Rep; 2018 Oct; 18(4):3649-3656. PubMed ID: 30132539
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway.
Hu T; Wei G; Xi M; Yan J; Wu X; Wang Y; Zhu Y; Wang C; Wen A
Int J Mol Med; 2016 Jul; 38(1):83-94. PubMed ID: 27176815
[TBL] [Abstract][Full Text] [Related]
3. Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the activation of the JAK2/STAT1 pathway.
Zhou D; Ding T; Ni B; Jing Y; Liu S
Int J Mol Med; 2019 Aug; 44(2):405-416. PubMed ID: 31173173
[TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1/VEGF-A/SDF-1α cascade.
Wei G; Yin Y; Duan J; Guo C; Zhu Y; Wang Y; Xi M; Wen A
Biomed Pharmacother; 2017 Apr; 88():409-420. PubMed ID: 28122306
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant effects of hydroxysafflor yellow A and acetyl-11-keto-β-boswellic acid in combination on isoproterenol-induced myocardial injury in rats.
Chen M; Wang M; Yang Q; Wang M; Wang Z; Zhu Y; Zhang Y; Wang C; Jia Y; Li Y; Wen A
Int J Mol Med; 2016 Jun; 37(6):1501-10. PubMed ID: 27121241
[TBL] [Abstract][Full Text] [Related]
6. Hydroxysafflor yellow A cardioprotection in ischemia-reperfusion (I/R) injury mainly via Akt/hexokinase II independent of ERK/GSK-3β pathway.
Min J; Wei C
Biomed Pharmacother; 2017 Mar; 87():419-426. PubMed ID: 28068632
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats.
He H; Yang X; Shi M; Zeng X; Yang J; Wu L; Li L
J Pharm Pharmacol; 2008 Jan; 60(1):115-23. PubMed ID: 18088512
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of heme oxygenase-1 expression by hydroxysafflor yellow A conferring protection from anoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes.
Liu SX; Zhang Y; Wang YF; Li XC; Xiang MX; Bian C; Chen P
Int J Cardiol; 2012 Oct; 160(2):95-101. PubMed ID: 21497407
[TBL] [Abstract][Full Text] [Related]
9. Protective Effect of Hydroxysafflor Yellow A on Nephropathy by Attenuating Oxidative Stress and Inhibiting Apoptosis in Induced Type 2 Diabetes in Rat.
Lee M; Zhao H; Liu X; Liu D; Chen J; Li Z; Chu S; Kou X; Liao S; Deng Y; Li H; Xie W
Oxid Med Cell Longev; 2020; 2020():7805393. PubMed ID: 32256962
[TBL] [Abstract][Full Text] [Related]
10. Effects of hydroxysafflor yellow A on proliferation and collagen synthesis of rat vascular adventitial fibroblasts induced by angiotensin II.
Yuan W; Yang D; Sun X; Liu W; Wang L; Li X; Man X; Fu Q
Int J Clin Exp Pathol; 2014; 7(9):5772-81. PubMed ID: 25337218
[TBL] [Abstract][Full Text] [Related]
11. Ulinastatin protects rats with myocardial infarction by activating Nrf2/NOS pathway.
Wang S; Cheng ZY; Chen XJ; Xue HZ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8990-8998. PubMed ID: 30575944
[TBL] [Abstract][Full Text] [Related]
12. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
13. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
Li L; Dong P; Hou C; Cao F; Sun S; He F; Song Y; Li S; Bai Y; Zhu D
J Ethnopharmacol; 2016 Jun; 186():224-233. PubMed ID: 27063983
[TBL] [Abstract][Full Text] [Related]
14. Hydroxysafflor Yellow A Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Calcium Overload and Apoptosis.
Ye J; Wang R; Wang M; Fu J; Zhang Q; Sun G; Sun X
Oxid Med Cell Longev; 2021; 2021():6643615. PubMed ID: 34093960
[TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury.
Jin M; Sun CY; Zang BX
Chin J Integr Med; 2016 Jan; 22(1):36-41. PubMed ID: 26015073
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
Jin M; Wang L; Wu Y; Zang BX; Tan L
Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
[TBL] [Abstract][Full Text] [Related]
17. Hydroxysafflor yellow A suppresses oleic acid-induced acute lung injury via protein kinase A.
Wang C; Huang Q; Wang C; Zhu X; Duan Y; Yuan S; Bai X
Toxicol Appl Pharmacol; 2013 Nov; 272(3):895-904. PubMed ID: 23933165
[TBL] [Abstract][Full Text] [Related]
18. Hydroxysafflor Yellow A Reprograms TLR9 Signalling Pathway in Ischaemic Cortex after Cerebral Ischaemia and Reperfusion.
Gong Z; Pan J; Li X; Wang H; He L; Peng Y
CNS Neurol Disord Drug Targets; 2018; 17(5):370-382. PubMed ID: 29732997
[TBL] [Abstract][Full Text] [Related]
19. Xin-Ji-Er-Kang ameliorates kidney injury following myocardial infarction by inhibiting oxidative stress via Nrf2/HO-1 pathway in rats.
Lian FZ; Cheng P; Ruan CS; Ling XX; Wang XY; Pan M; Chen ML; Shen AZ; Gao S
Biomed Pharmacother; 2019 Sep; 117():109124. PubMed ID: 31228798
[TBL] [Abstract][Full Text] [Related]
20. HSYA alleviates secondary neuronal death through attenuating oxidative stress, inflammatory response, and neural apoptosis in SD rat spinal cord compression injury.
Pei JP; Fan LH; Nan K; Li J; Dang XQ; Wang KZ
J Neuroinflammation; 2017 May; 14(1):97. PubMed ID: 28468657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]